Results 231 to 240 of about 1,218,633 (316)
BKI-1708 activity against the Cerep panel of 71 common liability targets: enzyme and Uptake assays.
Ryan Choi (278424), Matthew A. Hulverson (599782), Deborah A. Schaefer (8893544), Dana P. Betzer (21819896), Michael W. Riggs (8893541), Wenlin Huang (222075), Vicky Sun (21819899), Grant R. Whitman (4972075), Molly C. McCloskey (4972081), Kennan Marsh (591598), Wayne R. Buck (3289515), David S. Wagner (21819902), Junhai Yang (1335093), Andrew P. Bowman (3951674), Rita Ciurlionis (13321), Jubilee Ajiboye (21819905), Andrew Hemphill (267083), Dilep K. Sigalapalli (13363790), Samuel L.M. Arnold (10332519), Lynn K. Barrett (293068), Kayode K. Ojo (353587), Erkang Fan (544727), Wesley C. Van Voorhis (10332534) +22 moreopenalex +1 more sourceFibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.Wenhai Zhai, Yang Qu, Reziya Abuduxukuer, Kejia Zhang, Peng Zhang, Xin Tang, Huaimei Zhang, Lijuan Wang, Lichong Yang, Shuangxu Tan, Zhimei Yuan, Ce Han, Lili He, Yuping Zheng, Fenglan Zhao, Lijie Guo, Ligang Jiang, Jinfeng Li, Yongfei Jiang, Xuexia Zou, Dan Xu, Han Xu, Xiaojia Wang, Yingbin Qi, Xuefeng Hu, Yu Zhang, Zhen‐Ni Guo, Hang Jin, on behalf of the Biomarkers of Brain Injury Investigator Study Group +28 morewiley +1 more sourceOlink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods
We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang +9 morewiley +1 more source
